Stellenangebote für: - CLINICAL TRIALS

Alentis Therapeutics, the Claudin-1 Company, is on a mission to treat cancer and reverse fibrosis. To this end, we are rapidly advancing a clinical pipeline of anti-Claudin-1 monoclonal antibodies. Our team is committed to unlocking the broad potential of our therapeutic target Claudin-1 and bringing much-needed medicines to patients suffering from solid tumors as well as kidney, liver, and lung fibrosis. Tasks Your tasks: Assist in the overall management, quality control and maintenance of esse...

We make it GmbH is a company operating nationally in Switzerland. Thanks to many years of successful experience, it has a high level of competence in the personnel services sector. Concentration of placement activities on the core areas of industry, technology, office/administration, engineering, pharmaceuticals and IT. We make it GmbH places the highest demands on quality, ethics and discretion. For our customer, the company F. Hoffmann La Roche, we are searching for: Scientific Researcher (m/w...

Original Stellenanzeige auf StepStone.de - Klartext bei Geld! Finde den richtigen Job mit dem richtigen Gehalt. https://bit.ly/3llijzs Pentixapharm AG is a research-focused radiopharmaceutical and precision oncology company with operations focused on the preclinical, clinical development and manufacturing of the innovative theranostic drug peptide pair PentixaFor / PentixaTher and antibody-based pipeline. The clinical stage drugs specifically target the CXCR4 receptor, which is present in many r...

Are you seeking a purposeful and rewarding career opportunity where you can truly make a difference? Join us and be part of a dynamic team that values innovation, collaboration, and excellence. Let's shape the future of healthcare together! At Clario, we are committed to delivering high-quality professional services for our customers and patients. Our finance team in Germany is expanding, and with big ambitions and a clear vision for the future, now is the perfect time to join us as a Senior Fin...